GLP-3 RT
Size: 10mg
Metabolic Research
$85.00
$85.00
0% OFFBundle & Save
GLP-3 RT
Size: 10mg
GLP-3 RT is a triple agonist tool compound used to study GLP-1, GIP, and glucagon receptor pharmacology in vitro.

$85.00
$85.00
0% OFFBundle & Save
Product Description
GLP-3 RT – Research Peptide
GLP-3 RT is a triple agonist tool compound used to study GLP-1, GIP, and glucagon receptor pharmacology in vitro.
It is supplied for incretin-receptor binding, downstream signaling assays, and metabolic-pathway biochemistry in laboratory models.
Each vial contains high-purity lyophilized GLP-3 RT, manufactured under strict laboratory standards and verified with batch-specific Certificates of Analysis (COAs) to confirm identity and purity.
For laboratory research use only.
Certificate of Analysis
Third-party tested batch documentation
- Variant GLP-3 RT 20mg
- Lot R2001
- Net Peptide Content 23.12 mg
- Endotoxin Passed
- Heavy Metals Passed
- Product GLP-3 RT
- Variant GLP-3 RT 30mg
- Lot R3001
- Net Peptide Content 30.32 mg
- Endotoxin Passed
- Heavy Metals Passed
- Product GLP-3 RT
- Variant GLP-3 RT 30mg
- Lot PT-4802A1A8F7EA-1
- Net Peptide Content 30 mg
- Endotoxin Passed
- Heavy Metals Passed
- Product GLP-3 RT
- Variant GLP-3 RT 60mg
- Lot R6001
- Net Peptide Content 63.6 mg
- Endotoxin Passed
- Heavy Metals Passed
- Product GLP-3 RT
Stability Information
- Store lyophilized powder vials in the freezer when possible.
- After reconstitution, refrigerate at 2–8°C and protect from light and heat.
- Use within a typical research handling window after mixing. Swirl gently — never shake.
- Use sterile technique during reconstitution. For laboratory research use only.
Featured Products
High-purity compounds designed for laboratory research.
Related products
GLP-2 TZ
Metabolic Research Peptide
From $75.00
Metabolic Research Peptide
Select size
Frequently Asked Questions
Use these public databases to look up laboratory and preclinical literature on this compound. They are research context only — not medical advice, and not a claim that any given paper exists.
Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease
2024 · DOI: 10.1038/s41591-024-03018-2 · Sanyal AJ, et al.
Read source Lancet Diabetes & EndocrinologyEffects of Retatrutide on Body Composition
2025 · Coskun T, et al.
Read source PubChemGLP-3 RT Compound Information
NCBI compound record: structure, formula, identifiers, and physical properties.
Open PubChemFor Research Use Only
Products are intended solely for laboratory and scientific research. Not for human consumption, diagnostic, or therapeutic use. By purchasing, you confirm these materials will be used for in vitro research only.






